Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

MOXIFLOXACIN HYDROC

Active
SPE2DP-26-T-4476Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Moxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4476 for delivery to the Navy Expeditionary Central Facility in Williamsburg, VA, with a required delivery window of 20 days. The contract specifies a total quantity of 24 bottles, each containing 30 tablets, with a unit price of $24.00 per bottle and no variance allowed in quantity. The product must comply with stringent packaging and labeling standards as defined by Medical Marking Standard No. 1, superseding MIL-STD-129, and must be shipped in commercial, durable containers that ensure safe transport via common carrier at the lowest cost. Shelf life is strictly limited to 36 months and non-extendable, with storage required at controlled room temperature and protection from high humidity. The item is regulated by the FDA, and bidders must provide full manufacturer details including NDC numbers, with TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC. identified as potential suppliers. All packaging, marking, and shipment must adhere to DLA’s Master List of Technical and Quality Requirements, and hazardous material provisions apply as per FED-STD-313 and ASTM D3951 where applicable. Shipment must be made by the fastest traceable means, excluding parcel post, and must be palletized per RP001 requirements. The contract mandates delivery FOB destination, with inspection and acceptance occurring upon receipt at the delivery point, and all documentation must reflect compliance with DLA’s unit of issue and procurement standards.

General Info

24 bottles of 400 mg moxifloxacin, 30 tablets each, delivered FOB destination in 20 days, compliant with DLA and FDA standards.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 4 D STREET, WILLIAMSBURG, VA, 23185, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4476.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
JAMES MARIANI
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
MOXIFLOXACIN HYDROC
MOXIFLOXACIN HYDROCHLORIDE TABLETS<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
400 MG 30'S TABLETS PER BOTTLE. UNIT OF ISSUE "BOTTLE". STORE AT
CONTROLLED ROOM TEMPERATURE; AVOID HIGH HUMIDITY .. LABELING AND MARKING
MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY
2013.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 30 EA RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4476
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-7387-56 RISING PHARMA HOLDINGS, INC. 8FG82 P/N NDC57237-0156-30
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7006183184 0001 BT 24.000
NSN/MATERIAL:6505015034772
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
V4582F
NAVY EXPEDITIONARY CENTRAL FACILITY
CENTRAL ISSUE FACILITY
BLDG 4 D STREET
WILLIAMSBURG VA 23185
US
SPE2DP-26-T-4476
SECTION B
PR: 7006183184 PRLI: 0001 CONT’D
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
V4582F
NAVY EXPEDITIONARY CENTRAL FACILITY
CENTRAL ISSUE FACILITY
BLDG 4 D STREET
WILLIAMSBURG VA 23185
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) V4582F4026MH76
RDD: 777
PROJ: LP5 TP 2
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 06
DIC: A4A DIST: 9B ADV: 2A FC: P7
Need Ship Date:00/00/0000 Original Required Delivery Date:01/31/2024
SPE2DP-26-T-4476 NSN/Part Number: 6505-01-503-4772 Quantity: 24 BT Purchase Request: 7006183184QTY: 24 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
BUPIVACAINE AND EPINEP
Solicitation # SPE2DP-26-T-4478
The contract specifies the procurement of Bupivacaine and Epinephrine Injection, containing 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL (1:200,000), packaged in 1.8 mL cartridges, with a unit of issue of one case containing 50 cartridges. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and must have a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be commercially packaged to ensure safe transit under ASTM D3951 or applicable hazardous material standards if classified as hazardous under FED-STD-313. The supply must be free of intentional mercury or mercury compounds, except where functionally necessary and explicitly exempted, and any permitted mercury-containing components must meet Navy shockproof and secondary containment requirements. Delivery is required FOB destination within 20 days to the USS Delaware (SSN 791) at FPO AE 09583, with no variance allowed in quantity, and shipment must use traceable, expedited methods with no parcel post. The item is identified by NSN 6505-01-189-3973 and purchase request 7017729383, with a required delivery date of August 6, 2026. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, which supersedes any conflicting standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
VERAPAMIL HYDROCHLO
Solicitation # SPE2DP-26-T-4480
Verapamil Hydrochloride Extended-Release Tablets, 240 mg, are being procured in bottles of 100 tablets each, with a total quantity of two bottles required under contract SPE2DP-26-T-4480. The product must have a minimum of 31 months of shelf life remaining at the time of delivery, with a full 36-month shelf life specified and non-extendable. Packaging must comply strictly with DLA Packaging Requirements for Procurement and the latest Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection from damage during transit. All units must be commercially packaged in suitable exterior shipping containers, meeting the lowest freight rate standard for delivery to the specified destination. The item is regulated by the FDA, and the contracting official must confirm compliance via EBS referral. Manufacturer and distributor information includes Glenmark Pharmaceuticals Inc., USA and Cardinal Health 200, LLC, with the NDC number NDC68462-0260-01. The delivery is FOB destination, with a 20-day delivery window and no quantity variance permitted. Shipment must be traceable and cannot be sent via parcel post; instead, it must be transported using the FASTEST TRACEABLE MEANS with RDD 777 and referenced to the DLA vendor code V23027. The required delivery date is February 17, 2026, and the item is to be delivered to USS IWO JIMA LHD 7, FPO AA 34094. All packaging, labeling, and documentation must adhere to applicable DLA technical and quality requirements listed in the DLA Master List, which take precedence over ASTM D3951 and other commercial standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSE
Solicitation # SPE2DP-26-T-4477
Permectrin Cream Rinse is a 1% w/v topical medication packaged as a 2 fl oz plastic squeeze bottle, each unit including a comb for application, and supplied in individual units with a minimum of 21 months of remaining shelf life at time of receipt by the government, ensuring a 24-month total shelf life is maintained. The item is regulated by the FDA and must comply with all applicable medical, packaging, and hazardous materials standards including Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging requirements that ensure protection from damage during shipping and compliance with commercial standards for both interior and exterior containers. All shipments must include a current Safety Data Sheet (SDS) formatted per 29 C.F.R. 1910.1200, with labels meeting OSHA’s Hazard Communication Standard and the Globally Harmonized System, and these documents must be submitted for approval before contract award. Each shipment must also carry a copy of the SDS and be marked in accordance with the approved medical marking guidelines. The product is subject to DLA’s technical and quality requirements as outlined in the DLA Master List, and must comply with all applicable transportation regulations including 49 CFR and ICAO standards for hazardous materials. The NSN is 6505-01-256-4972, with two units requested under solicitation SPE2DP-26-T-4477, with a 20-day delivery requirement and a contract awarded to a government activity under the Department of Defense.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
TEST STRIPS AND COLOR
Solicitation # SPE2DS-26-T-305V
This contract specifies the procurement of urine test strips and color charts capable of detecting bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen, with each unit of issue consisting of 100 strips per bottle. The item is identified by NSN 6550-01-221-5400 and requires strict compliance with medical packaging and labeling standards, replacing all references to MIL-STD-129 with Medical Marking Standard No. 1. Each unit must be sealed in a protective container and packed in commercial exterior shipping containers suitable for safe transport at the lowest applicable freight rate. The product must have a non-extendable shelf life of 18 months, with no more than two months elapsed between manufacture and delivery to the government. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number, in accordance with the latest revision of MMS1C. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List, and the contract incorporates DLA packaging standards and the removal of government identification from non-accepted supplies. Covered defense information may apply, and the item is subject to delivery at Pearl Harbor, Hawaii within 20 days after order placement. The solicitation number is SPE2DS-26-T-305V, with responses due by August 10, 2026, and the procurement is managed by the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
GLOBULIN, RHO (D) IMMUN
Solicitation # SPE2DP-26-T-4482
GLOBULIN RHO (D) IMMUNE, USP, 300 MICROGRAMS per 1ML disposable syringe with safety mechanism, is intended for intramuscular injection only and is designated for adult use. The product must be stored at 2 to 8 degrees Celsius and must not be frozen. It is a prescription-only item and packaged individually as a single unit. The item is regulated by the FDA and requires confirmation through the EBS referral system, including submission of bidder and manufacturer details. The NSN is 6505-01-417-1250, and it is subject to DLA packaging and technical requirements referenced in the DLA Master List of Technical and Quality Requirements. As a hazardous material, it requires a current Material Safety Data Sheet (MSDS) to be submitted to DLA.MSDS@DLA.MIL and physically included with each shipment, with packaging compliant with 49 CFR and ICAO regulations. This solicitation, issued under SPE2DP-26-T-4482 by the Department of Defense’s Medical Supply Chain PHARM FSA, has a response deadline of August 10, 2026, with a delivery requirement of 20 days after award. The point of contact for inquiries is James Foggie, with email and phone provided for coordination.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
APPLICATOR, SILVER NITR
Solicitation # SPE2DP-26-T-4469
The applicator consists of a 75% silver nitrate and 25% potassium nitrate mixture fused to one end, measuring six inches or 1.524 centimeters, and is intended for topical use only with a prescription requirement. Each unit of issue is a container holding 100 applicators, which must be stored in the original closed package at room temperature in a dark, dry location, away from organic or oxidizable materials. The item is classified as a Type I (Code M) shelf-life item with a non-extendable shelf life of 24 months. It is regulated by the FDA, and buyers must submit a referral in EBS to confirm product details including bidder and manufacturer information. Hazardous materials regulations apply, requiring a current MSDS to be submitted via DLA.MSDS@DLA.MIL and included with each shipment, with packaging compliant to SPE2DP-26-T-4469 and applicable 49 CFR and ICAO standards. Removal of government identification from non-accepted supplies is required, and covered defense information potentially applies. The NSN is 6505-00-299-9672, with a single contract order quantity and a 10-day delivery requirement after award. The solicitation, issued under SPE2DP-26-T-4469, was posted on August 4, 2026, with responses due by August 10, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Nicholas Quigley listed as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
HYDROGEN PEROXIDE TOPI
Solicitation # SPE2DP-26-T-4481
Hydrogen Peroxide Topical Solution USP RP001 is a 3% stabilized solution intended for external topical use only, not for ingestion or application to the eyes or large body areas, and must not be used for more than one week. Each unit of issue is a 473-milliliter bottle, requiring tight closure, storage at controlled room temperature, protection from freezing and excessive heat, and must not be shaken. Labeling and packaging must strictly comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and all packaging must be commercially sealed and designed to prevent damage during transport. The item is regulated by the FDA and classified as a TYPE I (CODE M) item with a non-extendable shelf life of 24 months. As a hazardous material under OSHA’s revised Hazard Communication Standard effective June 1, 2015, suppliers must provide Safety Data Sheets (SDS) and compliant HCS labels per 29 C.F.R. 1910.1200, and must train employees on these requirements. The contract mandates delivery within 20 days to FPO AP 96693, FOB destination, with zero variance in quantity, and prohibits parcel post in favor of traceable shipping methods. The NSN is 6505-00-153-8480, with a contracted quantity of two bottles, procured under solicitation SPE2DP-26-T-4481, and all technical and quality requirements are governed by the DLA Master List, which supersedes ASTM D3951. Approved manufacturers include Medline Industries, LP, Cardinal Health 200, LLC, and McKesson Medical-Surgical Government, with the item identified by multiple NDC and part numbers. All deliveries must be palletized per RP001 requirements and marked per Medical Marking Standard No. 1.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, U
Solicitation # SPE2DP-26-T-4483
The contract specifies the procurement of 6 units of TOLNAFTATE POWDER, USP 1%, each unit being 45 grams, for delivery to a U.S. military vessel at FPO AP 96693. The item, identified by NSN 6505-01-480-7897 and NDC 57896-0199-45, must comply with stringent packaging and labeling requirements, including adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be commercially packaged in accordance with ASTM D3951 unless specified otherwise by DLA Master List requirements. The product has a non-extendable shelf life of 36 months and must be labeled and marked according to federal medical standards. Delivery is due within 20 days of contract award, with a firm fixed price and zero variance allowed in quantity. Freight must be shipped via the fastest traceable means—parcel post is prohibited—and transportation must follow DLA Procurement Notes C19 and C20. The contract requires FOB destination delivery, with inspection and acceptance occurring at the final destination. All packaging and palletization must conform to DLA Packaging Requirements for Procurement, and the supplier, GERI-CARE PHARMACEUTICALS CORP., must ensure compliance with all technical and quality specifications outlined in the DLA Master List. The solicitation was issued on August 4, 2026, with a response deadline of August 10, 2026, under contract number SPE2DP-26-T-4483.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4472
Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, designed for rectal administration and external use only. It is supplied in a collapsible tube and includes a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of ointment. The product must be stored at temperatures between 15 and 30 degrees Celsius or 59 to 86 degrees Fahrenheit to maintain stability and efficacy. This item has a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of the Medical Marking Standard No. 1. It is regulated by the FDA and classified as a Type I (Code Q) pharmaceutical item with specific supply chain requirements under DLA standards. The contract, issued under solicitation number SPE2DP-26-T-4472, requires delivery of five packages (PG) to be shipped FOB destination within ten days. The quantity variance is strictly zero percent, meaning exact fulfillment is mandatory. Inspection and acceptance occur at the destination, and packaging must comply with MIL-STD-2073-1E. The NSN is 6505-00-299-9535 and the manufacturer part number is NDC00536-1211-95, supplied by The Harvard Drug Group, L.L.C. All procurement activities are governed by DLA technical and quality requirements referenced in the DLA Master List, and the contracting official must submit an EBS referral to confirm regulatory compliance before award. The point of contact for the solicitation is Alec Deichman, and the place of performance is San Antonio, Texas.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
Federal
Custom Multi-Component Veterinary Drug Reference Standards (Amphenicols, Avermectins, Nitroimidazoles, Quinolones, Fluoroquinolones)The contract calls for the production of ISO 17034-certified reference standards targeting multiple veterinary drug classes, including chloramphenicol, ivermectin, metronidazole, and enrofloxacin, encompassing amphenicols, avermectins, nitroimidazoles, and fluoroquinolones. Each class will be delivered in two certified lots, designated as ICV and CCV, with each lot consisting of five 1mL ampules, ensuring consistent, traceable, and analytically validated materials for regulatory and laboratory use. Full analytical documentation must accompany each batch, confirming identity, purity, concentration, and stability in accordance with international metrological standards for reference materials. The work is to be performed at a facility located in Denver, Colorado, with a strict submission deadline of August 7, 2026, and is issued under a subcontract arrangement by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The North American Industry Classification System code 325412 confirms the manufacturing focus on pharmaceutical preparations, emphasizing the technical and regulatory rigor expected from the vendor to meet federal standards for reference standards used in veterinary drug testing and compliance monitoring.
FDA Office Of Acq Grant Svcs

POSTED

about 13 hours ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
Federal
Custom Multi-Component Veterinary Drug Reference Standards (Macrolides)The contract involves the production of ISO 17034-certified reference standards for macrolide antibiotics, specifically including Virginiamycin M1, to be delivered in two certified lots designated as ICV and CCV. Each lot will consist of five 1mL glass ampules, prepared under strict quality control to ensure purity, stability, and consistency suitable for use in LC-MS method calibration within veterinary drug testing. Full traceability of materials, processes, and analytical data is required, with each ampule accompanied by a detailed Certificate of Analysis that verifies identity, concentration, homogeneity, and stability under specified conditions. The standards must comply with international metrological requirements to support reliable analytical results in regulatory and diagnostic labs. The work is solicited as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services, with performance based in Denver, Colorado, 80225. The solicitation was posted on August 4, 2026, and responses are due by August 7, 2026, indicating a tight turnaround for technical proposal submission. The NAICS code 325412 classifies this as pharmaceutical and medicine manufacturing, underscoring the need for specialized expertise in reference material production. Deliverables must meet the highest regulatory benchmarks for certification, ensuring that the reference materials are fit for use in compliance testing, quality assurance, and method validation across veterinary drug monitoring programs.
FDA Office Of Acq Grant Svcs

POSTED

about 13 hours ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
SLED
Supply of Heterotrophic Plate Count (HPC) and Quanti-Tray ProductsThe contract entails the supply of Heterotrophic Plate Count (HPC) reagents and Quanti-Tray 2000 disposable multi-well plates used for quantitative bacterial analysis in water, targeting laboratories and agencies involved in water quality monitoring. The requirements are specifically for materials essential to standardized microbial testing protocols, ensuring accurate detection and quantification of heterotrophic bacteria in potable and environmental water samples. The products must meet established technical specifications to support compliance with regulatory and public health standards for water safety. This is a subcontract opportunity posted by the Mississippi Department of Health with a response deadline of August 24, 2026. The NAICS code 325412 indicates the procurement falls under the manufacturing of pharmaceutical and biological products, aligning with the specialized nature of the reagents and disposable trays. The place of performance and agency office details are not specified, suggesting delivery may be expected to multiple locations across Mississippi or to a central distribution point. The solicitation is open to qualified vendors capable of providing consistent, high-quality supplies with reliable logistics, and interested parties must submit proposals before the stated deadline to be considered.
MS DEPT of HEALTH

POSTED

1 day ago

DEADLINE

in 20 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
ALBUTEROL INHALATIO
Solicitation # SPE2DP-26-T-4470
Albuterol Inhalation Aerosol is a prescription-only medication supplied as a pressurized aluminum canister containing 60 actuations, each delivering 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, through a plastic actuator with a strap cap and built-in counter. The canister has a net weight of 8 grams and must be stored at 20° to 25°C (68° to 77°F), with allowable excursions between 15° and 30°C, following USP controlled room temperature guidelines. The inhaler must be kept with the mouthpiece down, shaken well before each use, and brought to room temperature prior to administration to ensure optimal performance. The product has a non-extendable shelf life of 18 months, and at the time of receipt by the first government activity, a minimum of 15 months of shelf life must remain. It is labeled and marked in compliance with SPE2DP-26-T-4470 and Medical Marking Standard No. 1C, and is classified as a hazardous material with flammable characteristics due to its pressurized contents. The canister must not be punctured, exposed to temperatures above 120°F, or disposed of in fire or incinerators. A current Material Safety Data Sheet (MSDS) is required and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL along with a completed cover sheet. Packaging must conform to 49 CFR and ICAO regulations for hazardous materials. The NSN is 6505-01-649-7928, with a quantity of 15 units ordered under Purchase Request 7017715897, with delivery required within 20 days of award. The solicitation is governed by DLA technical and quality requirements referenced in the DLA Master List, and buyers must confirm regulatory compliance through an EBS referral to the product specialist, providing manufacturer and bidder details. The item is regulated by the FDA and falls under Defense Information potentially subject to additional reporting.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
LIDOCAINE AND PRILOCAI
Solicitation # SPE2DP-26-T-4475
Lidocaine and prilocaine periodontal gel, marketed as ORAQIX at a 2.5%/2.5% concentration, is a microemulsion dental anesthetic supplied in individual blister-packed cartridges, each containing 1.7 grams of gel, with 20 cartridges per carton. Each cartridge comes with a single-use sterile blunt-tipped applicator and must be stored at controlled room temperature between 20°C and 25°C. The product is regulated by the FDA and classified as a prescription-only device with a non-extendable shelf life of 36 months, requiring labeling in compliance with MMS No. 1. Packaging must conform to DLA specifications, including MIL-STD-129 marking, and all technical and quality requirements from the DLA Master List take precedence over commercial standards. The item is identified by NSN 6505-01-656-9640 and manufacturer part number NDC66312-0110-20 from Dentsply Sirona Inc. The contract, issued under solicitation SPE2DP-26-T-4475, requires delivery of three packages to Seymour Johnson Air Force Base in North Carolina within 20 days of order placement, with FOB destination terms and zero tolerance for quantity variance. Shipping must be conducted via traceable means, explicitly prohibiting parcel post. The delivery is scheduled for August 5, 2026, and the contract includes federal acquisition compliance requirements, including referral protocols for FDA-regulated items through EBS and adherence to covered defense information protocols. The purchasing request number is 7017708438, and all packaging and unit of issue must align with DLA’s authorized standards, with point of contact Lawrence Garnett available for coordination.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
CALCIUM CHLORIDE INJEC
Solicitation # SPE2DP-26-T-4471
CALCIUM CHLORIDE INJECTION USP is procured as a 10 mL single-dose plastic syringe containing 1 gram of calcium chloride (100 mg/mL), packaged ten syringes per unit (1 PG = 10 EA), with a mandatory 24-month shelf life from the date of manufacture, no less than 21 months of which must remain at the time of delivery to the government. The product must be labeled in strict accordance with Medical Marking Standard No. 1, including the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number, and stored at 20 to 25°C (68 to 77°F). The item is regulated by the FDA and requires prior confirmation from the product specialist via EBS referral before award. Packaging must be commercial and designed to protect against damage, with exterior shipping containers ensuring safe, cost-effective transport to the delivery point. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The manufacturer is Pfizer Inc, with NDC 00409-1631-10, and the item is identified by NSN 6505-01-655-0700. Delivery is FOB destination in 20 days to Fort Campbell, Kentucky, with zero quantity variance permitted, and shipment must occur via traceable means, excluding parcel post. The contract reference is SPE2DP-26-T-4471, with an original required delivery date of August 5, 2026, and procurement governed by the DLA Master List of Technical and Quality Requirements, which take precedence over all other standards including ASTM D3951.
Medicinal and Botanical Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-26-T-4479
The contract is for the procurement of a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed for outdoor use and meeting stringent military specifications. The product is sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. Each unit of issue consists of a package containing 24 tubes of 3 ounces each, with a total shelf life of 24 months and a minimum of 21 months remaining at the time of government receipt. Storage must occur between 15°C and 30°C in a cool, dry environment. The item is regulated by the FDA and classified as a Type I (Code M) item with a non-extendable shelf life. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection during transit. All packaging and labeling must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. The product must be shipped in commercial exterior containers suitable for safe delivery by common carrier via the fastest traceable means, with no use of parcel post permitted. Delivery is FOB destination with a 20-day lead time, and the sole delivery point is the USS ZUMWALT DDG 1000 at FPO AP 96693. The shipment must be palletized in accordance with DLA packaging requirements and labeled with the NSN 6505-01-657-9247 and contract line item number 7017729391. The order quantity is one package, and no variance in quantity is permitted. The procurement is issued under solicitation SPE2DP-26-T-4479, with a response deadline of August 10, 2026, and a required delivery date of August 6, 2026. Transportation and shipping protocols are governed by DLAD procedural notes C19 and C20, and all vendors must use the Vendor Shipping Module for tracking. The contracting office is part of the Department of Defense’s Medical Supply Chain, and any bid must be referred to the product specialist in EBS with manufacturer and item details for confirmation prior to award.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details